116 related articles for article (PubMed ID: 9110055)
1. Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies.
Sowunmi A; Salako LA; Walker O
Afr J Med Med Sci; 1996 Mar; 25(1):53-9. PubMed ID: 9110055
[TBL] [Abstract][Full Text] [Related]
2. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo-controlled study.
Black HR; Sollins JS; Garofalo JL
Am J Hypertens; 2000 May; 13(5 Pt 1):468-74. PubMed ID: 10826396
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with doxazosin in general medical practice.
Rosenthal J
Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
[TBL] [Abstract][Full Text] [Related]
4. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
Os I; Stokke HP
J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
[TBL] [Abstract][Full Text] [Related]
5. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
Levy D; Walmsley P; Levenstein M
Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
7. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
Englert RG; Mauersberger H
Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
[TBL] [Abstract][Full Text] [Related]
8. A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.
Anegón M; Esteban J; Jiménez-García R; Sanz de Burgoa V; Martínez J; Gil de Miguel A
Clin Ther; 2002 May; 24(5):786-97. PubMed ID: 12075946
[TBL] [Abstract][Full Text] [Related]
9. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
van den Hogen AL
Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
[TBL] [Abstract][Full Text] [Related]
11. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
12. An open, noncomparative study of doxazosin in essential hypertension: experience in general practice in The Netherlands.
Naber FB
Am Heart J; 1991 Jan; 121(1 Pt 2):273-9. PubMed ID: 1824650
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertension.
Tan KW; Frise SA
Clin Ther; 1997; 19(3):459-70. PubMed ID: 9220210
[TBL] [Abstract][Full Text] [Related]
14. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
Davis BR; Cutler JA; Furberg CD; Wright JT; Farber MA; Felicetta JV; Stokes JD;
Ann Intern Med; 2002 Sep; 137(5 Part 1):313-20. PubMed ID: 12204014
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
Taylor SH
Am Heart J; 1991 Jan; 121(1 Pt 2):362-6. PubMed ID: 1824662
[TBL] [Abstract][Full Text] [Related]
16. A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.
Castrignano R; D'Angelo A; Pati T; Al Awady M; Tronca R; Crepaldi G
Am Heart J; 1988 Dec; 116(6 Pt 2):1778-84. PubMed ID: 2904750
[TBL] [Abstract][Full Text] [Related]
17. Amlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studies.
Sowunmi A; Walker O; Salako LA
Afr J Med Med Sci; 1996 Sep; 25(3):213-6. PubMed ID: 10457792
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).
Guthrie RM; Siegel RL
Clin Ther; 1999 Oct; 21(10):1732-48. PubMed ID: 10566569
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
20. The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine.
Lindner UK; von Manteuffel GE; Stafunsky M
Am Heart J; 1988 Dec; 116(6 Pt 2):1814-20. PubMed ID: 2904756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
